Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c1854
Identifier NCT06175949
Trial Title A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DRUG: HRS-7085 Tablets; DRUG: HRS-7085 simulant
Participant Information
Sponsor Shandong Suncadia Medicine Co., Ltd.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-12-23
Primary Completion Date 2025-06-24
Completion Date 2025-07-24